A detailed history of Rothschild Investment LLC transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Rothschild Investment LLC holds 421 shares of LGND stock, worth $48,099. This represents 0.0% of its overall portfolio holdings.

Number of Shares
421
Previous 406 3.69%
Holding current value
$48,099
Previous $34.2 Million 23.17%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$82.7 - $110.11 $1,240 - $1,651
15 Added 3.69%
421 $42.1 Million
Q2 2024

Jul 30, 2024

BUY
$68.53 - $87.91 $27,823 - $35,691
406 New
406 $34.2 Million
Q4 2023

Jul 31, 2024

BUY
$49.57 - $72.63 $9,914 - $14,526
200 Added 49.26%
606 $43.3 Million

Others Institutions Holding LGND

About LIGAND PHARMACEUTICALS INC


  • Ticker LGND
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,882,800
  • Market Cap $1.93B
  • Description
  • Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...
More about LGND
Track This Portfolio

Track Rothschild Investment LLC Portfolio

Follow Rothschild Investment LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild Investment LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rothschild Investment LLC with notifications on news.